I recently received the following question:
I have type 2 diabetes, I'm on Medicare, and I take 80 units of insulin daily. Currently, I am taking Lantus [insulin glargine] and I need 10 pens per month. My current provider says that the insulin cost is over $700 per month, which means I will hit the doughnut... Read more
A friend who is living with diabetes recently forwarded me an invitation to listen to a webinar (internet seminar) titled, "Reversing Diabetes types 1.5, 2 and 3." I was intrigued enough by the title to sign up to participate.
"Reversing diabetes" is, of course, a catchphrase similar to "miracle cure," and should have... Read more
Back in 2012, a reader asked "Have you heard of a proposed new drug based on the hormone irisin?"
My reply to the reader was brief ("It's way too early to speculate whether this will lead to new therapy for any condition."), but I decided to... Read more
I recently read a discussion about "Advocating for better diabetes care in hospitals" and again was reminded of the perpetual problem of providing excellence of diabetes care for hospitalized... Read more
The manufacturer of a very popular insulin product, Lantus (insulin glargine), has a problem.The drug, which had 5.72 billion euros ($7.7 billion) in sales last year, loses patent protection soon. Typically, when a drug goes off-patent, profits plummet, as competitors flood the market with less-expensive competitors. There's already a ... Read more